Quantitative imaging that turns MRI into evidence, for trial sponsors, clinicians, and the patients between them.
Quantitative imaging biomarkers that de-risk every phase, from MASH to oncology, across multi-site programmes.
A 15-minute MRI, a quantitative report, and the confidence of a biomarker the literature has been building for fourteen years.
Each reads a different organ. Together with PAIR-MASH™ and the broader PAIR family, they form Perspectum’s complete platform: quantitative MRI plus AI pathology, with digital endoscopy on the roadmap, through one vendor.
cT1 mapping for liver tissue characterisation. A peer-reviewed quantitative MRI biomarker, regulatory-recognised across UK, EU and US.
Explore LiverMultiScan
Multi-organ MRI assessment. Built for long COVID, complex disease, and whole-body insight in a single appointment.
Explore
Quantitative biliary tree visualisation. The first non-invasive way to see what only ERCP could before.
Explore
Pre-surgical liver assessment with Couinaud-segment volumetry, fat, and fibroinflammation in one report.
Explore
Quantitative visceral and subcutaneous fat from a single breath hold, added to a LiverMultiScan exam. For endocrinology, GLP-1 response and obesity care.
Explore